Abnormalities in subsets of B and T cells in Mexican patients with inborn errors of propionate metabolism: Observations from a single-center case series

• E.A. Medina-Torres ^[1] ; M. Vela-Amieva ^[1] ; L. Galindo-Campos ^[2] ; I. Ibarra-González ^[3] ; S. Espinosa-Padilla ^[1] ; S. Guillén-López ^[1] ; L. López-Mejía ^[1] ; C. Fernández-Lainez ^[1]
  1. [1] Instituto Nacional de Pediatria

     Instituto Nacional de Pediatria

     México

     
  2. [2] Laboratorio de Errores Innatos del Metabolismo y Tamiz, Instituto Nacional de Pediatría, Secretaría de Salud, México; Alumno Tesista de la Facultad de Química de la Universidad Nacional Autónoma de México, UNAM, México.
  3. [3] Unidad de Genética de la Nutrición, Instituto de Investigaciones Biomédicas-Instituto Nacional de Pediatría, UNAM, México.

  Mostrar afiliaciones +
• Localización: Allergologia et immunopathologia: International journal for clinical and investigate allergology and clinical immunology, ISSN-e 1578-1267, ISSN 0301-0546, Vol. 49, Nº. 1, 2021, págs. 101-106
• Idioma: inglés
• Enlaces
  • Texto completo
• Resumen

  • Background: Propionate inborn errors of metabolism (PIEM), including propionic (PA) and methylmalonic (MMA) acidemias, are inherited metabolic diseases characterized by toxic accumulation of propionic, 3-hydroxypropionic, methylcitric, and methylmalonic organic acids in biological fluids, causing recurrent acute metabolic acidosis events and encephalopathy, which can lead to fatal outcomes if managed inadequately. PIEM patients can develop hematological abnormalities and immunodeficiency, either as part of the initial clinical presentation or as chronic complications. The origin and characteristics of these abnormalities have been studied poorly. Thus, the aim of the present work was to evaluate and describe lymphoid, myeloid, and erythroid cell population profiles in a group of clinically stable PIEM patients.

    Methods: This was a retrospective study of 11 nonrelated Mexican PIEM patients. Clinical, biochemical, nutritional, hematological, and lymphocyte subsets were analyzed.

    Results: Despite being considered clinically stable, 91% of patients had hematological or immunological abnormalities. The absolute lymphocyte subset counts were low in all patients but one, with CD4+ T-cell lymphopenia, being the most common one. Furthermore, of the 11 studied subjects, nine presented with a low CD4/CD8 ratio. Among the observed hematological alterations, bicytopenia was the most common (82%) one, followed by anemia (27%).

    Conclusion: Our results contribute to the landscape of immunological abnormalities observed previously in PIEM patients; these abnormalities can become a life-threatening chronic complications because of the increased risk of opportunistic diseases. These findings allow us to propose the inclusion of monitoring immune biomarkers, such as subsets of lymphocytes in the follow up of PIEM patients.